Tumor necrosis factor (TNF)-α plays a pivotal role in tissue destruction and overall RA pathogenesis; therefore, the development of anti-TNF-α therapy has been a milestone in the treatment of RA. This evidence concerns the gene TNF and rheumatoid arthritis.